Ninety-Minute Exclusion of Acute Myocardial Infarction By Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I
- 25 September 2001
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Cell Metabolism
- Vol. 104 (13), 1483-1488
- https://doi.org/10.1161/hc3801.096336
Abstract
Background Diagnostic strategies with ECG and serum cardiac markers have been used to rule out acute myocardial infarction in 6 to 12 hours. The present study evaluated whether a multimarker strategy that used point-of-care measurement of myoglobin, creatine kinase (CK)-MB, and troponin I could exclude acute myocardial infarction in ≤3 hours. Methods and Results We prospectively enrolled consecutive patients (n=817) in the emergency department who were evaluated for possible acute myocardial infarction. In patients with nondiagnostic ECGs, we measured CK-MB, troponin I, and myoglobin with a point-of-care device at presentation and at 90 minutes, 3 hours, and 9 hours. Standard central laboratory testing of CK-MB was done at the same time intervals, and triage decisions were made by emergency physicians who were unaware of point-of-care results. Sensitivity and negative predictive value were compared for both the multimarker, point-of-care approach and the central laboratory strategy. Sensitivity and negative predictive value for point-of-care combination of myoglobin and troponin I by 90 minutes was 96.9% and 99.6%, respectively. CK-MB measurements and blood sampling at 3 hours did not improve sensitivity or negative predictive value. Median time from sampling to reporting of results was 71.0 minutes for the central laboratory versus 24.0 minutes for the point-of-care device ( P Conclusions Acute myocardial infarction can be excluded rapidly in the emergency department by use of point-of-care measurements of myoglobin and troponin I during the first 90 minutes after presentation.Keywords
This publication has 21 references indexed in Scilit:
- Comparison between strategies using creatine kinase-MB(mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiograThe American Journal of Cardiology, 2000
- A Prospective Study of an Algorithm Using Cardiac Troponin I and Myoglobin as Adjuncts in the Diagnosis of Acute Myocardial Infarction and Intermediate Coronary Syndromes in a Veteran's HospitalClinical Cardiology, 2000
- A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: The serial markers, acute myocardial infarction and rapid treatment trial (SMARTT)Journal of the American College of Cardiology, 2000
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJournal of the American College of Cardiology, 2000
- Ruling out acute myocardial infarction early with two serial creatine kinase-MBmassdeterminationsPublished by Oxford University Press (OUP) ,1999
- A Rapid Diagnostic and Treatment Center for Patients With Chest Pain in the Emergency DepartmentAnnals of Emergency Medicine, 1995
- Evaluation of a New Rapid Quantitative Immunoassay for Serum Myoglobin Versus CK-MB for Ruling Out Acute Myocardial Infarction in the Emergency DepartmentAnnals of Emergency Medicine, 1994
- Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency roomThe American Journal of Cardiology, 1991
- Detection of myoglobin by radioimmunoassay in human sera: Its usefulness and limitations as an emergency room screening test for acute myocardial infarctionAmerican Heart Journal, 1978
- Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction.JCI Insight, 1975